National Comprehensive Cancer Network

NCCN Guidelines^® & Clinical Resources

JNCCN Supplements and Special Features

NCCN convenes experts from within and beyond NCCN Member Institutions to expand on issues discussed in the NCCN Guidelines and to discuss issues outside the scope of the NCCN Guidelines. *

View the latest JNCCN Supplements

View archived JNCCN Supplements

2016 Supplements and Special Features

• NCCN Policy Paper: Value, Access, and Cost of Cancer Care Delivery at Academic Cancer Centers
• Optimizing Patient Care in Chronic Myelogenous Leukemia: A Multidisciplinary Approach

2013 Supplements

• Data Needs in Oncology: "Making Sense of the Big Data Soup"
• Early Initiation of Palliative Care Interventions in Patients With Cancer, With an Emphasis on Management of Breakthrough Pain
• Measuring Quality in Oncology: Challenges and Opportunities
• NCCN Task Force Report: Bone Health in Cancer Care

2012 Supplements

• NCCN White Paper: Equity in Cancer Care: Pathways, Protocols, and Guidelines
• Current Issues in Chronic Myeloid Leukemia: Monitoring, Resistance, and Functional Cure
  CME Activity • Post Test
• Summaries from the International Photodynamic Medicine Symposium

2011 Task Force Supplements

• NCCN Task Force Report: Evaluating the Clinical Utility of Tumor Markers in Oncology
• NCCN Task Force Report: Tyrosine Kinase Inhibitor Therapy Selection in the Management of Patients With Chronic Myelogenous Leukemia
• NCCN Task Force Report: Optimizing Treatment of Advanced Renal Cell Carcinoma With Molecular Targeted Therapy

Other 2011 Supplements

• NCCN Molecular Testing White Paper: Effectiveness, Efficiency, and Reimbursement
• NCCN Biosimilars White Paper: Regulatory, Scientific, and Patient Safety Perspectives
• JNCCN Special Edition: NCCN Oncology Pharmacy & Policy

2010 Task Force Supplements

• NCCN Task Force Report: Update on the Management of Patients with Gastrointestinal Stromal Tumors
• NCCN Task Force Report: Specialty Pharmacy
• Preliminary Report: The Development of the NCCN Comparative Therapeutic Index™ as a Clinical Evaluative Process for Existing Data in Oncology

Other 2010 Supplements

• Addressing Challenges in Multiple Myeloma Management in an Era of New Therapeutics
• The Abu Dhabi Declaration: Adapted Application of NCCN Clinical Practice Guidelines in Oncology in the Middle East and North Africa Region
• JNCCN Special Edition: NCCN Oncology Pharmacy & Policy
• Reassessing the Standard of Care in Indolent Lymphoma: A Clinical Update to Improve Clinical Practice

2009 Task Force Supplements

• NCCN Task Force Report: Transfusion and Iron Overload in Patients with Myelodysplastic Syndromes
• NCCN Task Force Report: Estrogen Receptor and Progesterone Receptor Testing in Breast Cancer by Immunohistochemistry
• NCCN Task Force Report: Management of Neuropathy in Cancer
• NCCN Task Force Report: Molecular Markers in Leukemias and Lymphomas
• NCCN Task Force Report: Bone Health in Cancer Care
• NCCN Task Force Report: Clinical Utility of PET in a Variety of Tumor Types
• NCCN Task Force Report: Management of Dermatologic and Other Toxicities Associated With EGFR Inhibition in Patients With Cancer

Other 2009 Supplements

• The Science and Practice of Bone Health in Oncology
• Epigenetic Modulation in Hematologic Malignancies: Challenges and Progress

2008 Supplements

• Breast Cancer in the Older Woman
• mTOR Inhibition in Solid Tumors
• Oral Chemotherapy
• Prevention and Management of Mucositis in Cancer Care

2007 Supplements

• Gastrointestinal Stromal Tumors (GISTs)
• PET/CT Scanning in Cancer

2006 Supplements

• NCCN Task Force Report: Adjuvant Therapy for Breast Cancer
• NCCN Task Force Report: Bone Health and Cancer Care
• HER2 Testing in Breast Cancer: NCCN Task Force Report and Recommendations

* Please see individual task force reports for more information on CME/CE credits.

These files are for individual use only; printing out multiple copies is strictly prohibited. You may not reproduce and/or distribute any file in other formats or media or for any other purposes. For multiple copies/reprints, please contact Betty Ann Gilchrist.

Each JNCCN supplement is copyrighted by the National Comprehensive Cancer Network. All rights reserved. This file may not be used for any other purposes without further permission from the National Comprehensive Cancer Network. Permission can be requested at here.

You are not permitted to translate, reformat, add to, rearrange, delete pages, extract portions, modify, adapt, or change any parts of this file without further permission from the National Comprehensive Cancer Network.

You are not permitted to place advertisements or logos of any kind on or within this file.

You are not permitted to distribute this file electronically (including via internet, CD-ROM, PDA, DVD, etc...).